A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Amyotrophic Lateral Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
Contact: Study coordinator (Julian Grosskreutz, MD) · julian.grosskreutz@neuro.uni-luebeck.de · +49 451 500 43450Istituto Neurologico "Carlo Besta", Milan, Italy
AOU Città della Salute e della Scienza di Torino, Torino, Italy
Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
Contact: Study coordinator (Leonard Van den Berg, MD) · l.h.vandenberg@umcutrecht.nl · +31 088-755 7939Karolinska Universitetssjukhuset, Stockholm, Sweden
Contact: Study coordinator (Staffan Rosenborg, MD) · staffan.rosenborg@regionstockholm.se · +46-8-123 810 48
Study leads
Medical Monitor
Study Director
Leal Therapeutics, Inc